Intercure To Buy ISHI In All-Stock Transaction Find Out More

2025-09-19 10:13:45

(MENAFN- AsiaNet News)

InterCure (INCR) on Friday announced that it will acquire premium medical cannabis technology and brand company Botanico, also known as ISHI.

The company said that it would acquire ISHI in two phases. The company would initially acquire 50% of equity for about 2.47 million InterCure ordinary shares. The remaining 50% will be acquired either 24 months from the initial closing, in consideration for an additional 2.46 million InterCure ordinary shares, or upon ISHI achieving positive operating profitability for at least three consecutive months, InterCure said.

INCR stock traded 3% lower in the pre-market session at the time of writing.

Get updates to this developing story <directly on Stocktwits.

MENAFN19092025007385015968ID1110085056

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.